PRPO Precipio, Inc. Stock Quote

PRPO [NASD]

Healthcare | Diagnostics & Research | USA

Index	-	P/E	-	EPS (ttm)	-1.69	Insider Own	0.20%	Shs Outstand	17.23M	Perf Week	17.14%
Market Cap	46.24M	Forward P/E	-	EPS next Y	-	Insider Trans	8.83%	Shs Float	17.02M	Perf Month	37.32%
Income	-15.90M	PEG	-	EPS next Q	-	Inst Own	3.30%	Short Float	9.25%	Perf Quarter	29.86%
Sales	4.80M	P/S	9.63	EPS this Y	83.20%	Inst Trans	1.72%	Short Ratio	1.93	Perf Half Y	139.17%
Book/sh	0.86	P/B	3.34	EPS next Y	-	ROA	-81.20%	Target Price	-	Perf Year	42.08%
Cash/sh	0.14	P/C	21.02	EPS next 5Y	20.00%	ROE	-124.70%	52W Range	0.55 - 8.00	Perf YTD	38.65%
Dividend	-	P/FCF	-	EPS past 5Y	68.20%	ROI	-91.20%	52W High	-64.13%	Beta	2.84
Dividend %	-	Quick Ratio	0.80	Sales past 5Y	20.30%	Gross Margin	13.50%	52W Low	421.82%	ATR	0.22
Employees	50	Current Ratio	0.90	Sales Q/Q	100.00%	Oper. Margin	-	RSI (14)	67.26	Volatility	12.74% 9.39%
Optionable	No	Debt/Eq	0.09	EPS Q/Q	32.70%	Profit Margin	-	Rel Volume	0.91	Prev Close	2.96
Shortable	Yes	LT Debt/Eq	0.04	Earnings	Nov 19 AMC	Payout	-	Avg Volume	817.00K	Price	2.87
Recom	2.00	SMA20	22.34%	SMA50	26.66%	SMA200	53.68%	Volume	742,476	Change	-3.04%

Jan-20-21 10:00AM	Precipio Signs HemeScreen Deals with Two Leading Oncology Groups GlobeNewswire
Dec-10-20 10:15AM	Precipio Signs Sales & Marketing Agreement for HemeScreen with Major Oncology Distributor GlobeNewswire
Nov-19-20 03:15PM	Precipio, Inc. to Host Earnings Call ACCESSWIRE
Nov-11-20 09:00AM	Precipio Announces Q3-2020 Shareholder Update Call GlobeNewswire
Oct-06-20 10:00AM	Precipio & ADS Biotec Launch Seven Beta sites for IV-Cell GlobeNewswire -6.69%
Sep-22-20 10:30AM	Precipio Launches its Proprietary HemeScreen AML (Acute Myeloid Leukemia) Molecular Panel GlobeNewswire
Sep-04-20 09:00AM	Precipio Announces a Shareholder Call to Discuss its COVID-19 Progress and Future Plans GlobeNewswire +12.50%
Aug-20-20 01:00PM	Precipio & ADS Biotec Sign Global Distribution Agreement for IV-Cell GlobeNewswire +6.25%
Aug-07-20 09:00AM	Precipio Announces Q2-2020 Corporate Update Call For Shareholders GlobeNewswire -8.67%
Aug-04-20 10:45AM	Precipio Launches Covid-19 Antibody Test in its CLIA laboratory GlobeNewswire +25.24%
Jul-31-20 07:45AM	The Daily Biotech Pulse: Sanofi-GSK Land $2.1B Funding For Coronavirus Vaccine, D-Day For GW Pharma, FDA Nod For Roche Benzinga -55.14%
Jul-30-20 10:15AM	Precipio Announces Commercial Launch of COVID-19 Antibody Test GlobeNewswire +469.11%
Jul-22-20 10:15AM	Precipio Announces Q2-2020 Unaudited Pathology Services Revenue Increased Approximately 50% over Q120 GlobeNewswire -8.13%
Jul-01-20 02:00PM	Precipio Regains Listing Compliance with NASDAQ Minimum Bid Requirement GlobeNewswire -8.45%
Jun-09-20 10:00AM	Precipio Adds Another HemeScreen Customer GlobeNewswire -17.91%
May-19-20 03:00PM	Precipio, Inc. to Host Earnings Call ACCESSWIRE
May-15-20 10:00AM	Q1-2020 Net Revenues increase 77% over Q4-2019 to $1.2M GlobeNewswire
May-12-20 05:00PM	Precipio Announces Q1-2020 Corporate Update Call For Shareholders GlobeNewswire
Apr-20-20 02:28AM	China Development Bank, General Electric Cancel Boeing 737 MAX Jet Order SmarterAnalyst
Apr-13-20 02:27PM	General Electric Uses Biopharma Sale Proceeds to Cut Debt Pile SmarterAnalyst
Apr-06-20 10:00AM	Precipio Launches New HemeScreen Reagent Rental Program GlobeNewswire
Mar-20-20 09:30AM	Company Update During the COVID-19 Era GlobeNewswire -17.36%
Mar-16-20 09:30AM	Precipio Completes the Transaction with Poplar Healthcares Oncometrix Hematopathology Division GlobeNewswire
Feb-26-20 11:30AM	Precipio achieves impressive initial results of Artificial Intelligence Decision-Support Tool GlobeNewswire
Feb-18-20 10:00AM	Precipio in advanced discussions with Poplar Healthcare towards a multi-faceted strategic partnership GlobeNewswire
Jan-28-20 09:00AM	TrialJectory and Precipio Partner to Provide Cancer Patients with First-of-its-Kind Diagnostic and Clinical Trial-Matching Service PR Newswire +5.76%
07:30AM	Precipio Provides Clarification To Amendment No.1 to Form S-1 Filing GlobeNewswire
Jan-15-20 07:30AM	Precipio Provides Clarification To Recent S-1 Filing GlobeNewswire
Jan-13-20 05:00PM	Precipio announces shareholder update call to kick off 2020 GlobeNewswire
Dec-17-19 10:30AM	Precipio Announces First IV-Cell Commercial Order from Northwell Health ACCESSWIRE +25.94%
Dec-04-19 09:15AM	Precipio Announces the Resignation of Samuel Riccitelli and the Introduction of Richard Sandberg to its Board of Directors ACCESSWIRE
Nov-14-19 12:15PM	Precipio Wins $750,000 Pharma Project ACCESSWIRE
09:15AM	Precipio Reports Superior Performance For IV-Cell(TM) In Side-By-Side Analysis Conducted by Two Major External Laboratories ACCESSWIRE
Nov-04-19 05:30PM	Precipio Announces Q3-2019 Corporate Update Call for Shareholders ACCESSWIRE
Oct-09-19 12:00PM	Partners HealthCare and Precipio Enter into Pathology Services Agreement ACCESSWIRE +9.75%
Oct-02-19 04:30PM	Precipio Announces Shareholder Update Call on Commercial Progress ACCESSWIRE -7.76%
Sep-30-19 11:10AM	First Substantial Customer: Tennessee Oncology Internalizes Precipios HemeScreen GlobeNewswire -7.12%
Sep-27-19 04:28PM	A Lack Of Momentum Leads To A Lesson In Patience Benzinga -14.07%
03:08PM	A Look At Benzinga Pro's Most-Searched Tickers For September 27, 2019 Benzinga
Sep-26-19 10:53AM	Clinical Validations for IV-Cell and HemeScreen Completed GlobeNewswire +50.00%
Sep-05-19 09:15AM	Precipio and University of Pennsylvania Enter into Joint Collaboration Agreement for Pathology Diagnostics GlobeNewswire
Aug-21-19 03:00PM	Precipio, Inc. to Host Earnings Call ACCESSWIRE
Aug-13-19 11:30AM	Precipio Pathology Sales Metrics Demonstrate Continuous Improvement in Q2 2019 GlobeNewswire
09:15AM	Precipio Announces Q2-2019 Corporate Update Call for Shareholders GlobeNewswire
Jul-22-19 10:00AM	Global Expansion Efforts Begin Yielding Results GlobeNewswire
Jun-25-19 09:15AM	Precipio and H3 Biomedicine Sign Second Development Agreement GlobeNewswire
Jun-17-19 10:39AM	Precipio CEO Provides Update Letter To Shareholders GlobeNewswire -21.08%
Jun-04-19 09:10AM	Precipio Signs Exclusive Manufacturing Agreement for IV-Cell GlobeNewswire +5.05%
May-30-19 10:15AM	Precipio Pathology Sales Performance Metrics Demonstrate Substantial Improvement in Q1-2019 GlobeNewswire
May-23-19 09:55AM	Precipio CEO enrolls in long term stock purchase plan GlobeNewswire
May-15-19 11:40AM	Precipio Regains Nasdaq Listing Compliance GlobeNewswire +9.69%
May-06-19 09:20AM	Precipio Conducts IV-Cell Validation Trial with a Prominent Laboratory GlobeNewswire
May-03-19 09:11AM	Precipio Successfully Completes Nasdaq Hearing Process GlobeNewswire -13.77%
May-01-19 06:06PM	Precipio Reminder of Corporate Update Shareholder Call GlobeNewswire +38.84%
Apr-29-19 12:02PM	Precipio News: PRPO Stock Surges on Deal With Hospitals in Egypt InvestorPlace
08:35AM	Precipio Signs First Major International Services Contract GlobeNewswire
Apr-26-19 11:00AM	Precipio Takes Final Step towards Regaining Nasdaq Compliance GlobeNewswire -31.70%
Apr-24-19 09:01AM	Precipio Launches Global Expansion Strategy GlobeNewswire
Apr-18-19 08:45AM	Mr. Ori Karev Joins Precipio Executive Team As Chief Strategy Officer GlobeNewswire +15.85%
Apr-15-19 09:15AM	Precipio Announces 2018 Year-End Corporate Update Call for Shareholders GlobeNewswire +41.82%
Apr-09-19 09:15AM	Precipio Identifies Manufacturer for its IV-Cell Media GlobeNewswire +31.20%
Apr-03-19 07:38AM	Precipios HemeScreen Adopted by Methodist Health GlobeNewswire +9.10%
Mar-27-19 07:47AM	Precipio Receives Expected Delisting Determination from Nasdaq Staff and Will Request Nasdaq Hearing GlobeNewswire -12.57%
Mar-11-19 08:45AM	Precipio CEO Issues Shareholder Update Letter GlobeNewswire +12.80%
Mar-05-19 07:40AM	Continued ICP Orders From Japanese Customers GlobeNewswire
Feb-18-19 05:00PM	Precipio Provides Corporate Update Shareholder Call GlobeNewswire
Feb-14-19 08:18AM	Precipio 2018 Revenues Increase 66% over 2017; Company Takes Substantial Cost-Cutting Measures Towards Profitability GlobeNewswire +18.84%
Jan-29-19 07:47AM	Precipio Gains Recognition on NY Radio Station WHPC Show My Hometown As Innovator Battling Cancer Misdiagnosis GlobeNewswire -6.68%
Jan-15-19 07:47AM	Makati Medical Center in the Philippines Adopts Precipios ICE COLD-PCR Mutation Enrichment Technology for Liquid Biopsies GlobeNewswire
Jan-14-19 08:00AM	Best Bounces to Play the Rally ACCESSWIRE -13.81%
Jan-10-19 07:45AM	Precipio Announces First US Government Customer for ICE COLD-PCR Mutation Enrichment Technology GlobeNewswire +42.48%
Jan-08-19 07:45AM	Precipio Files Patent for HemeScreen, its Novel Molecular Assay GlobeNewswire
Dec-12-18 08:15AM	Precipio Reports Strong Mid-Quarter Growth GlobeNewswire
Dec-04-18 09:15AM	Precipio Announces $1.2 Million Securities Purchase Agreement With Participation from Members of Its Board of Directors, and other Investors GlobeNewswire -8.37%
Nov-27-18 10:10AM	The Reason Healthcare Stocks Are Being Called Home By Investors ACCESSWIRE
09:38AM	Precipio ICE COLD-PCR Technology Selected by the University of Cincinnati Medical Center for Liquid Biopsy Study GlobeNewswire
Nov-16-18 09:32AM	Letter to Shareholders to accompany recent proxy filing GlobeNewswire -6.82%
Nov-15-18 09:00AM	Precipio Announces Third Quarter 2018 Corporate Update Call for Shareholders GlobeNewswire
Nov-14-18 09:30AM	4 Healthcare Stocks To Watch On Wednesday ACCESSWIRE
09:15AM	Webinar to Highlight Technology Underlying Precipios ICE COLD-PCR on November 20, 2018 GlobeNewswire
Nov-01-18 09:15AM	Precipio and PerkinElmer Collaborate to Provide Solutions for Liquid Biopsy Testing Workflows GlobeNewswire +7.41%
Oct-23-18 09:15AM	Precipio Expands ICE COLD-PCR Menu for Breast, Colon and Endometrial Cancers GlobeNewswire
Oct-18-18 07:36AM	Innovation Behind Precipios ICE-COLD PCR Platform Spotlighted in Media GlobeNewswire
Oct-16-18 07:47AM	Precipio Announces Third Quarter 2018 Revenues Estimated to be 2.4 Times Third Quarter of 2017 Revenues GlobeNewswire +5.57%
Oct-03-18 07:47AM	Precipio Launches HemeScreen, a Disruptive, Proprietary Molecular Test for Hematologic Cancers GlobeNewswire
Sep-27-18 07:37AM	Precipio Granted 180 Day NASDAQ Extension to Regain Compliance GlobeNewswire
Sep-21-18 09:18AM	Precipio Enters into Exchange Agreement to Restructure Remaining Legacy Accounts Payable for approximately 20% of Original ~$5M GlobeNewswire
Sep-20-18 07:37AM	Precipio Expands ICE-COLD PCR Lung Cancer Mutation Detection Offering GlobeNewswire
Aug-23-18 07:00AM	Precipio, Inc. to Host Earnings Call ACCESSWIRE -8.42%
Aug-22-18 09:45PM	Precipio Reminds Investors of Conference Call with Management for Corporate Update and Second Quarter Results GlobeNewswire +7.91%
Aug-17-18 07:37AM	Precipio Announces Second Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
Aug-09-18 07:37AM	Precipio Appoints New Board Member to Replace Departing Director GlobeNewswire
Jul-19-18 08:10AM	Todays Research Reports on Stocks to Watch: Texas Instruments and Precipio ACCESSWIRE -12.08%
Jul-18-18 07:37AM	Precipio Announces 213% Year-over-Year Revenue Growth in Preliminary Q2-2018 Results GlobeNewswire +29.14%
Jun-26-18 08:00AM	Precipio and Nucleai Partner to Develop Artificial Intelligence-Powered Hemepath Solution GlobeNewswire
07:05AM	Initiating Free Research Reports on Quest Diagnostics and Three Other Medical Research Equities ACCESSWIRE
Jun-19-18 07:38AM	Precipio Updates Commercial Pipeline for its ICE-COLD PCR Liquid Biopsy Technology GlobeNewswire -6.44%
Jun-15-18 08:11PM	Precipio Inc. Announces Adjournment of Annual Meeting of Shareholders GlobeNewswire
Jun-14-18 12:19PM	Precipio Reminds Shareholders to Vote Before the Annual General Meeting on June 15, 2018 GlobeNewswire
Jun-12-18 08:00AM	Precipio Reminds Shareholders to Vote Before the Annual General Meeting on June 15, 2018 GlobeNewswire

Precipio, Inc., a cancer diagnostics company, provides diagnostic products and services in the United States oncology market. Its product consists of clinical diagnostic services. The company's clinical diagnostic services focus on the diagnosis of different hematopoietic or blood-related cancers to oncologists. Its cytogenetics media IV-Cell enables laboratories to arrive at more accurate results; and HemeScreen panel enables hospitals and laboratories to run an important genetic mutation test. It serves oncologists, hospitals, reference laboratories, and pharma and biotech companies. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment, such as the Yale School of Medicine and Harvard's Dana-Farber Cancer Institute. The company is based in New Haven, Connecticut.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Sabet Ahmed Zaki	Chief Operating Officer	Dec 01	Buy	2.23	222	495	4,728	Dec 03 04:31 PM
DANIELI ILAN	Chief Executive Officer	Dec 01	Buy	2.23	1,111	2,478	20,437	Dec 03 04:31 PM
Sabet Ahmed Zaki	Chief Operating Officer	Sep 01	Buy	2.16	130	281	4,506	Sep 03 09:10 PM
DANIELI ILAN	Chief Executive Officer	Sep 01	Buy	2.15	1,150	2,467	19,326	Sep 03 09:09 PM
Sabet Ahmed Zaki	Chief Operations Officer	Jul 07	Buy	0.96	281	270	4,207	Jul 14 04:15 PM
Sabet Ahmed Zaki	Chief Operations Officer	Jul 07	Buy	1.60	169	270	4,376	Jul 14 04:16 PM
DANIELI ILAN	Chief Executive Officer	Jul 06	Buy	0.96	2,585	2,482	18,176	Jul 07 04:31 PM
DANIELI ILAN	Chief Executive Officer	Jul 06	Buy	1.60	1,550	2,480	15,591	Jul 07 04:30 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience